These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 9535195)

  • 1. Active drug substance impurity profiling part II. LC/MS/MS fingerprinting.
    Nicolas EC; Scholz TH
    J Pharm Biomed Anal; 1998 Jan; 16(5):825-36. PubMed ID: 9535195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active drug substance impurity profiling part I. LC/UV diode array spectral matching.
    Nicolas EC; Scholz TH
    J Pharm Biomed Anal; 1998 Jan; 16(5):813-24. PubMed ID: 9535194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impurity Profile of Bronchodilators used in Asthma: A Critical Review.
    Prajapati KJ; Kothari CS
    Curr Drug Discov Technol; 2018; 15(4):272-304. PubMed ID: 28875855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Five Oxidative Degradation Impurities and One Process Impurity of Suvorexant Drug Substance by LC-MS/MS, HR-MS and 1D, 2D NMR: Validation of Suvorexant Drug Substance and Process Impurities by HPLC and UPLC.
    Rajana N; Devi DR; Kumar Reddy DN; Babu JM; Basavaiah K; Balakumaran K
    J Chromatogr Sci; 2020 Apr; 58(5):433-444. PubMed ID: 32134104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D; Basniwal PK
    J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applicability of mass spectrometry to detect coeluting impurities in high-performance liquid chromatography.
    Antonovich RS; Keller PR
    J Chromatogr A; 2002 Sep; 971(1-2):159-71. PubMed ID: 12350111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levothyroxine sodium revisited: A wholistic structural elucidation approach of new impurities via HPLC-HRMS/MS, on-line H/D exchange, NMR spectroscopy and chemical synthesis.
    Ruggenthaler M; Grass J; Schuh W; Huber CG; Reischl RJ
    J Pharm Biomed Anal; 2017 Feb; 135():140-152. PubMed ID: 28024262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A high pH based reversed-phase high performance liquid chromatographic method for the analysis of aminoglycoside plazomicin and its impurities.
    Tan L; Wlasichuk KB; Schmidt DE; Campbell RL; Hirtzer P; Cheng L; Karr DE
    J Pharm Biomed Anal; 2012 Jul; 66():75-84. PubMed ID: 22459505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of a trap-free two-dimensional liquid chromatography combined with ion trap/time-of-flight mass spectrometry for separation and characterization of impurities and isomers in cefpiramide.
    Wang J; Xu Y; Wen C; Wang Z
    Anal Chim Acta; 2017 Nov; 992():42-54. PubMed ID: 29054149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fenofibrate raw materials: HPLC methods for assay and purity and an NMR method for purity.
    Lacroix PM; Dawson BA; Sears RW; Black DB; Cyr TD; Ethier JC
    J Pharm Biomed Anal; 1998 Nov; 18(3):383-402. PubMed ID: 10096833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination and quantification of related substances and degradation products in bictegravir by full factorial design evaluated HPLC and mass spectrometry.
    Kumar SRJ; Rao VK; Katari NK; Jyothi NS; Kowtharapu LP
    Anal Methods; 2023 Mar; 15(10):1274-1285. PubMed ID: 36852477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification, isolation and characterization of impurities of clindamycin palmitate hydrochloride.
    Bharathi Ch; Jayaram P; Sunder Raj J; Saravana Kumar M; Bhargavi V; Handa VK; Dandala R; Naidu A
    J Pharm Biomed Anal; 2008 Dec; 48(4):1211-8. PubMed ID: 18947955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation, synthesis and characterization of impurities in celecoxib, a COX-2 inhibitor.
    Satyanarayana U; Rao DS; Kumar YR; Babu JM; Kumar PR; Reddy JT
    J Pharm Biomed Anal; 2004 Jun; 35(4):951-7. PubMed ID: 15193741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid detection and identification of impurities in ten 2-naphthalenamines using an atmospheric pressure solids analysis probe in conjunction with ion mobility mass spectrometry.
    Pan H; Lundin G
    Eur J Mass Spectrom (Chichester); 2011; 17(3):217-25. PubMed ID: 21828413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between liquid chromatography-UV detection and liquid chromatography-mass spectrometry for the characterization of impurities and/or degradants present in trimethoprim tablets.
    Barbarin N; Henion JD; Wu Y
    J Chromatogr A; 2002 Sep; 970(1-2):141-54. PubMed ID: 12350089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of RP UPLC-TOF/MS, stability indicating method for omeprazole and its related substances by applying two level factorial design; and identification and synthesis of non-pharmacopoeial impurities.
    Jadhav SB; Kumar CK; Bandichhor R; Bhosale PN
    J Pharm Biomed Anal; 2016 Jan; 118():370-379. PubMed ID: 26600119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NMR and mass spectrometric characterization of vinblastine, vincristine and some new related impurities--part II.
    Háda V; Dubrovay Z; Lakó-Futó A; Galambos J; Gulyás Z; Aranyi A; Szántay C
    J Pharm Biomed Anal; 2013 Oct; 84():309-22. PubMed ID: 23177164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of impurity profiling of arbekacin sulfate by ion-pair liquid chromatography coupled with pulsed electrochemical detection and online ion suppressor-ion trap-time off light mass spectrometry.
    Chen Z; Zhu X; Geng Y; Dai J; Tang S; Adams E; Chen D; Yuan Y
    J Pharm Biomed Anal; 2022 Nov; 221():115061. PubMed ID: 36183632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Separation and characterization of unknown impurities in rutin tablets using trap-free two-dimensional liquid chromatography coupled with ion trap/time-of-flight mass spectrometry.
    Wang J; Ren X; Wen C; Xu Y; Chen Y
    Rapid Commun Mass Spectrom; 2020 May; 34(10):e8739. PubMed ID: 31986235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impurity profile and spectrum characteristics of the isomers in cefamandole nafate using high- performance liquid chromatography/high-performance size exclusion chromatography tandem ion trap/time-of-flight mass spectrometry.
    Wang F; Gao J; Chen H; Zhu B; Li P; Wang J; Hong L
    Rapid Commun Mass Spectrom; 2022 Dec; 36(23):e9399. PubMed ID: 36114650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.